Zobrazeno 1 - 10
of 211
pro vyhledávání: '"m-RNA vaccine"'
Autor:
Piras, Alessandra1 (AUTHOR), Melis, Giada2 (AUTHOR), Cugusi, Lucia3 (AUTHOR), Bassareo, Pier Paolo4,5,6 (AUTHOR) piercard@inwind.it
Publikováno v:
Pediatric Reports. Dec2022, Vol. 14 Issue 4, p401-409. 9p.
Autor:
Al-Jahhafi, Abhaa Sulaiyam1, Al-Sawaai, Asma Ali1, Al-Bimani, Zamzam Khalifa2, Al-Bulushi, Naima Khamis2 nkd004@hotmail.com
Publikováno v:
Asia Oceania Journal of Nuclear Medicine & Biology. Jan2024, Vol. 12 Issue 1, p65-68. 4p.
Publikováno v:
Asia Oceania Journal of Nuclear Medicine and Biology, Vol 12, Iss 1, Pp 65-68 (2024)
The surge of the COVID-19 pandemic (December / 2019 - May/2023) and its catastrophic effect worldwide have necessitated emergent intervention to reduce its influence on people's health and life. To eliminate and reduce the impact of COVID-19 infectio
Externí odkaz:
https://doaj.org/article/ee9478d0929741dd8151450f7e1064f8
Publikováno v:
Pediatric Reports, Vol 14, Iss 4, Pp 401-409 (2022)
One of the most powerful weapons against COVID-19 is vaccines. After the worldwide spread of the disease, m-RNA vaccines were authorized not only in adult patients, but also in children and adolescents aged 12–18. Since then, alarming reports of ca
Externí odkaz:
https://doaj.org/article/c9e316984f2d444f997b4bc0bb1f1b3a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Natacha Bordry, Anne-Claire Mamez, Chiara Fedeli, Chloé Cantero, Cyril Jaksic, Pilar Ustero Alonso, Caroline Rayroux, Gregory Berra, Vera Portillo, Maeva Puntel, Sabine Yerly, Sébastien Bugeia, Garance Gutknecht, Mariagrazia Di Marco, Nicolas Mach, Paola Marina Soccal, Yves Chalandon, Alexandra Calmy, Alfredo Addeo
Publikováno v:
Vaccines, Vol 11, Iss 8, p 1284 (2023)
Immunocompromised patients (ICPs) have a higher risk of developing severe forms of COVID-19 and experience a higher burden of complications and mortality than the general population. However, recent studies have suggested that the antibody response t
Externí odkaz:
https://doaj.org/article/a3d0d4b3586044cab2c911fd560b6d23
Publikováno v:
Journal of Japanese Association for Acute Medicine; February 2024, Vol. 35 Issue: 2 p64-70, 7p
Autor:
Villanego, F., Crespo, M., Lopez, V., Zarraga, S., Oppenheimer, F., Llinas, L., Andres, A., Diaz, C., Ruiz, M., Moreso, F., Rodriguez-Benot, A., Beneyto, I., Cabello, S., Jimenez, C., Canal, C., Molina, M., Pascual, J., Mazuecos, A.
Publikováno v:
AMERICAN JOURNAL OF TRANSPLANTATION
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::9cc6730145e909285fe73491b6a40664
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=17120
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=17120
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Helene Resch, Florian Thalhammer, Sophie Brunner, Bernhard Parschalk, Andrea Foit, Maximilian Schnetzinger, Robert Strassl, Tibor Spath, Gabriela Kornek, Rebeka Savic
Publikováno v:
SSRN Electronic Journal.
Background: The identification of SARS-CoV-2 antigen or RNA in a respiratory specimen collected from a person ≥14 days after completing all recommended doses of authorized COVID-19 vaccine series is a rare condition and defined as „breakthrough i